You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/24/2014

Company Name Symbol %Change
KNIGHTSBRIDG VLCCF
11.44%
MODINE MANUF MOD
6.73%
INFINERA COR INFN
6.24%
LTX CREDENCE LTXC
6.02%
AMERICAN RAI ARII
6.02%
Future Horizons in the $4.5 Billion European Molecular Diagnostics Market - Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country

Print Share

Dec 13, 2012 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/cj6fvj/future_horizons) has announced the addition of the "Future Horizons in the European Molecular Diagnostics Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Competitive Profiles - Abbott - Affymetrix - Agilent - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Illumina - Innogenetics/Solvay - Kreatech - Li-Cor Biosciences - Life Technologies - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis - Orchid CellMark - Ortho-Clinical Diagnostics - Qiagen - Roche - Sequenom - Shimadzu - Siemens For more information visit http://www.researchandmarkets.com/research/cj6fvj/future_horizons

CONTACT: Research and Markets, Laura Wood, Senior Manager. press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Diagnostics (http://www.researchandmarkets.com/categories.asp?cat_id=59&campaign_id=cj6fvj)

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

(C)1994-2012 M2 COMMUNICATIONS

**********************************************************************

As of Sunday, 12-09-2012 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
04-23-2012 for DHR @ $52.54.

As of Sunday, 12-09-2012 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
03-06-2012 for NVS @ $53.55.

As of Sunday, 12-09-2012 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
04-04-2012 for SI @ $97.43.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2012 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.